Recent advances in the analysis of phenothiazine drugs and their metabolites using high performance liquid chromatography.
HPLC procedures with electrochemical or ultraviolet detection were developed in order to analyze plasma samples from patients and volunteers who had received antipsychotic drugs. Procedures were described for the determination of chlorpromazine and trimeprazine in human plasma. The described procedures for chlorpromazine and trimeprazine demonstrated sufficient sensitivity for their use in pharmacokinetic studies following low single oral doses of these agents. The HPLC-EC procedures for chlorpromazine and trimeprazine were compared with GC-MS and radioimmunoassay procedures, respectively.
D000328:Adult; D014150:Antipsychotic Agents / Q000097:blood*; D001711:Biotransformation; D002746:Chlorpromazine / Q000097:blood; D002851:Chromatography, High Pressure Liquid; D004563:Electrochemistry; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007700:Kinetics; D008297:Male; D013881:Thioridazine / Q000097:blood; D014291:Trimeprazine / Q000097:blood
D014150:Antipsychotic Agents; D014291:Trimeprazine; D013881:Thioridazine; D002746:Chlorpromazine